AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Cyclically Adjusted Revenue per Share: €12.03 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORSE:LJM1R AS Latvijas Juras medicinas centrs ORSE:LJM1R
59 GF Score
Price €7.80
GF Value €7.78
! 3 Warning Signs
View Full Analysis

What is AS Latvijas Juras medicinas centrs Cyclically Adjusted Revenue per Share?

AS Latvijas Juras medicinas centrs ORSE:LJM1R 59 Cyclically Adjusted Revenue per Share is €12.03 as of Dec. 2025. GuruFocus rates ORSE:LJM1R with a GF Score™ of 59/100 and a GF Value™ of €7.78. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

AS Latvijas Juras medicinas centrs's adjusted revenue per share for the three months ended in Dec. 2025 was €3.137. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €12.03 for the trailing ten years ended in Dec. 2025.

During the past 12 months, AS Latvijas Juras medicinas centrs's average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of AS Latvijas Juras medicinas centrs was 10.20% per year. The lowest was 2.70% per year. And the median was 7.35% per year.

As of today (2026-09-15), AS Latvijas Juras medicinas centrs's current stock price is €7.80. AS Latvijas Juras medicinas centrs's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was €12.03. AS Latvijas Juras medicinas centrs's Cyclically Adjusted PS Ratio of today is 0.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of AS Latvijas Juras medicinas centrs was 1.81. The lowest was 0.38. And the median was 0.80.


AS Latvijas Juras medicinas centrs  (ORSE:LJM1R) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AS Latvijas Juras medicinas centrs's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.80/12.03
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of AS Latvijas Juras medicinas centrs was 1.81. The lowest was 0.38. And the median was 0.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


AS Latvijas Juras medicinas centrs Cyclically Adjusted Revenue per Share Related Terms


AS Latvijas Juras medicinas centrs Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for AS Latvijas Juras medicinas centrs's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AS Latvijas Juras medicinas centrs Cyclically Adjusted Revenue per Share Chart

AS Latvijas Juras medicinas centrs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.99 9.99 10.73 11.42 12.03

AS Latvijas Juras medicinas centrs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.42 11.65 11.83 12.00 12.03

ORSE:LJM1R vs HCA, THC, ENSG: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AS Latvijas Juras medicinas centrs Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AS Latvijas Juras medicinas centrs's Cyclically Adjusted PS Ratio falls into.


ORSE:LJM1R
59GF Score
AS Latvijas Juras medicinas centrs ORSE:LJM1R
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AS Latvijas Juras medicinas centrs Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AS Latvijas Juras medicinas centrs's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=3.137/324.0540*324.0540
=3.137

Current CPI (Dec. 2025) = 324.0540.

AS Latvijas Juras medicinas centrs Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 1.872 238.132 2.547
201606 1.852 241.018 2.490
201609 1.826 241.428 2.451
201612 2.002 241.432 2.687
201703 1.993 243.801 2.649
201706 1.920 244.955 2.540
201709 1.915 246.819 2.514
201712 1.519 246.524 1.997
201803 2.088 249.554 2.711
201806 2.106 251.989 2.708
201809 1.852 252.439 2.377
201812 2.296 251.233 2.962
201903 2.236 254.202 2.850
201906 2.212 256.143 2.798
201909 2.279 256.759 2.876
201912 2.362 256.974 2.979
202003 2.277 258.115 2.859
202006 1.768 257.797 2.222
202009 2.521 260.280 3.139
202012 2.286 260.474 2.844
202103 2.756 264.877 3.372
202106 3.022 271.696 3.604
202109 2.860 274.310 3.379
202112 3.067 278.802 3.565
202203 3.366 287.504 3.794
202206 3.115 296.311 3.407
202209 2.670 296.808 2.915
202212 0.000 296.797 0.000
202303 2.823 301.836 3.031
202306 2.962 305.109 3.146
202309 3.259 307.789 3.431
202312 0.000 306.746 0.000
202403 3.175 312.332 3.294
202406 3.085 314.175 3.182
202409 3.216 315.301 3.305
202412 0.000 315.605 0.000
202503 3.245 319.799 3.288
202506 3.273 322.561 3.288
202509 3.204 324.800 3.197
202512 3.137 324.054 3.137

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €12.03 mean?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a Cyclically Adjusted Revenue per Share of €12.03 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on AS Latvijas Juras medicinas centrs and its competitors.
Is AS Latvijas Juras medicinas centrs' Cyclically Adjusted Revenue per Share too high?
AS Latvijas Juras medicinas centrs' current Cyclically Adjusted Revenue per Share is €12.03. Overall, AS Latvijas Juras medicinas centrs has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does AS Latvijas Juras medicinas centrs' Cyclically Adjusted Revenue per Share compare to HCA and THC?
AS Latvijas Juras medicinas centrs' Cyclically Adjusted Revenue per Share of €12.03 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on AS Latvijas Juras medicinas centrs and its competitors. AS Latvijas Juras medicinas centrs's current Cyclically Adjusted Revenue per Share is €12.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AS Latvijas Juras medicinas centrs stock overvalued right now?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a current Cyclically Adjusted Revenue per Share of €12.03. The stock's GF Value™ is €7.78, compared to a current price of €7.80 — trading 0.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €12.03. AS Latvijas Juras medicinas centrs' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For AS Latvijas Juras medicinas centrs (ORSE:LJM1R), the current Cyclically Adjusted Revenue per Share is €12.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?

Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued. The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.

Key valuation signals for ORSE:LJM1R:

  • Cyclically Adjusted Revenue per Share: €12.03
  • GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AS Latvijas Juras medicinas centrs Business Description

Address Patversmes iela 23, Riga, LVA, LV-1005
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score

Get the complete analysis for ORSE:LJM1R

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.80
Price
€7.78
GF Value